Description of Research Expertise

Dr. Beslow’s research focuses on neonatal and childhood cerebrovascular diseases including various stroke subtypes (arterial ischemic stroke, hemorrhagic stroke, cerebral sinovenous thrombosis), arteriopathies (e.g. focal cerebral arteriopathy, moyamoya), and cerebral vascular malformations.

Dr. Beslow has been a member of the International Pediatric Stroke Study (IPSS) since 2007 and has leadership positions in the IPSS and International Pediatric Stroke Organization (IPSO). She also participates in multiple studies including pediatric stroke clinical trials and is the Chair of the IPSO Outcomes Working Group. Dr. Beslow has led several studies on pediatric stroke in the setting of COVID-19 and has several active projects related to pediatric stroke, pediatric brain vascular malformations, and hereditary hemorrhagic telangiectasia (HHT). Dr. Beslow is a part of several centers of excellence and special programs related to brain vascular disease including the Penn HHT Center Center of Excellence, Penn Cerebral Cavernous Malformation (CCM) Center, CHOP Comprehensive Vascular Anomalies Program (CVAP), and CHOP Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED).

Pediatric Stroke: risk factors, measurement tool validation for pediatric stroke and cerebrovascular malformations, predictors of outcome, COVID-19 and pediatric stroke, neurovascular effects of sickle cell disease

Pediatric cerebral vascular malformations; hereditary hemorrhagic telangiectasia, cerebral cavernous malformations, Sturge Weber Syndrome

Description of Clinical Expertise

Dr. Beslow is a member of the CHOP Pediatric Stroke Program and completed a clinical and research fellowship in pediatric stroke. She also is a neurology consultant in the CHOP pediatric, neonatal, and cardiac intensive care units. Dr. Beslow's clinics focus on pediatric stroke, arteriopathies like moyamoya,
and brain vascular malformations like AVMs and cavernous malformations. She has a special interest in HHT and was a research fellow with the Brain Vascular Malformation Consortium's HHT project. In addition to the CHOP Pediatric Stroke Program, Dr. Beslow is a part of several Centers of Excellence and special programs related to brain vascular disease including the Penn HHT Center and CHOP HHT Clinic, Penn CCM Center, CHOP Complex Vascular Anomalies Program, and CHOP Sickle Cell and Red Cell Disorders Curative Therapy Center.

Pediatric Stroke, Pediatric Cerebral Vascular Malformations (neurology member of the Comprehensive Vascular Anomalies Program [CVAP], Hereditary Hemorrhagic Telangiectasia (HHT), Cerebral Cavernous Malformations (CCMs) (https://www.angioma.org/penn-medicine/?amp), Cerebrovascular Effects of Sickle Cell Disease (neurology consultant to Sickle Cell and Red Cell Disorder Curative Therapy Center [CuRED]), Hypoxic Ischemic Encephalopathy, Pediatric Neurocritical Care Consultation, General Child Neurology

Description of Other Expertise

Board eligible in General Pediatrics